Evidence map›Paper›PMID 35884803›Full record

ReviewBiomedicines2022

Probiotics: Evolving as a Potential Therapeutic Option against Acetaminophen-Induced Hepatotoxicity.

Saikat Dewanjee, Tarun K Dua, Paramita Paul, Abhijit Dey, Jayalakshmi Vallamkondu, Sonalinandini Samanta, Ramesh Kandimalla, Vincenzo De Feo

Open access · goldAbstract readReview
In one paragraph

Review in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Nutrients · 2024
    Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 2 countries.

Saikat DewanjeeAdvanced Pharmacognosy Research Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India.ORCID 0000-0001-9085-4226
Tarun K DuaDepartment of Pharmaceutical Technology, University of North Bengal, Raja Rammohunpur 734013, India.ORCID 0000-0001-5136-7564
Paramita PaulDepartment of Pharmaceutical Technology, University of North Bengal, Raja Rammohunpur 734013, India.ORCID 0000-0002-8077-9530
Abhijit DeyDepartment of Life Sciences, Presidency University, Kolkata 700073, India.ORCID 0000-0002-5750-0802
Jayalakshmi VallamkonduDepartment of Physics, National Institute of Technology, Warangal 506004, India.
Sonalinandini SamantaDepartment of Dermatology (Skin & Venereology), Employee's State Insurance Corporation Medical College & Hospital, Patna 801103, India.
Ramesh KandimallaDepartment of Biochemistry, Kakatiya Medical College, Warangal 506007, India.
Vincenzo De FeoDepartment of Pharmacy, University of Salerno, 84084 Fisciano, Italy.ORCID 0000-0002-1070-3207
North Bengal University · INEmployees' State Insurance Model Hospital · INJadavpur University · INKakatiya University · INNational Institute of Technology Warangal · INPresidency University · INUniversity of Salerno · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acetaminophen (APAP) is the most common prescription medicine around the world for the treatment of pain and fever and is considered to be a safe drug at its therapeutic dose. However, a single overdose or frequent use of APAP can cause severe acute liver injury. APAP hepatotoxicity is a prevalent cause of acute liver disease around the world and the lack of suitable treatment makes it a serious problem. In recent years, there has been a surge in interest in using probiotics and probiotic-derived products, known as postbiotics, as health and disease negotiators. A growing body of evidence revealed that they can be equally effective against APAP hepatotoxicity. Different probiotic bacteria were found to be pre-clinically effective against APAP hepatotoxicity. Different postbiotics have also shown exciting results in preclinical models of APAP hepatotoxicity. This review summarized the protective roles and mechanisms of the different probiotic bacteria and postbiotics against APAP hepatotoxicity, with critical discussion. A brief discussion on potential novel probiotics and postbiotics for oxidative liver injury was also included. This review was written in an attempt to pique the interest of researchers in developing a safe therapeutic option against oxidative liver damage using probiotics and/or postbiotics as dietary supplements.

Indexed as

acetaminophenhepatotoxicitynutraceuticalspostbioticsprobiotics

Identifiers

PMID35884803
PMCPMC9312935
OpenAlexW4283463810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.